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Abstract
Surgical site occurrences (SSOs) affect up to or over 25% of patients undergoing
operative procedures, with the subset of surgical site infections (SSIs) being the most
common. Commercially available closed incision negative pressure therapy (ciNPT)
may offer surgeons an additional option to manage clean, closed surgical incisions.
We conducted an extensive literature search for studies describing ciNPT use and
assembled a diverse panel of experts to create consensus recommendations for when
using ciNPT may be appropriate. A literature search of MEDLINE, EMBASE and the
Cochrane Central Register of Controlled Trials using key words ‘prevention’, ‘negative
pressure wound therapy (NPWT)’, ‘active incisional management’, ‘incisional vacuum
therapy’, ‘incisional NPWT’, ‘incisional wound VAC’, ‘closed incisional NPWT’,
‘wound infection’, and ‘SSIs’ identified peer-reviewed studies published from 2000
to 2015. During a multidisciplinary consensus meeting, the 12 experts reviewed the
literature, presented their own ciNPT experiences, identified risk factors for SSOs and
developed comprehensive consensus recommendations. A total of 100 publications
satisfied the search requirements for ciNPT use. A majority presented data supporting
ciNPT use. Numerous publications reported SSI risk factors, with the most common
including obesity (body mass index ≥30 kg/m2); diabetes mellitus; tobacco use; or
prolonged surgical time. We recommend that the surgeon assess the individual patient’s
risk factors and surgical risks. Surgeons should consider using ciNPT for patients
at high risk for developing SSOs or who are undergoing a high-risk procedure or a
procedure that would have highly morbid consequences if an SSI occurred.
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Introduction
The World Health Organization estimated that surgeons
performed over 234 million major surgeries (i.e., operative
procedures involving significant risks to the patient) globally
each year (1). In industrialised countries, major complications
(i.e. those that are potentially life-threatening and require
hospitalisation and therapeutic intervention) occur in over 25%
of inpatient surgical procedures (1). In the United States (US)
alone, surgical site infections (SSIs) account for 36% of all
health care-associated infections, which are a major cause of
morbidity, putting 8 million US patients at risk for developing
an SSI annually (2,3). Current standards of care for preventing
SSI include preoperative prophylactic systemic antibiotics
(for selected surgical procedures); preoperative antiseptic
shower/bath; aseptic incision site surgical preparation; and
sterile and meticulous surgical technique (4). Yet, the contin-
ued high SSI rates demonstrate the need for new preventative
methods.
Traditionally, surgeons have closed surgical incisions with
primary intention using sutures, staples, tissue adhesives, paper
tape or a combination of these methods. However, negative
pressure wound therapy (NPWT) has become a viable wound
care option since its introduction two decades ago. For many
different operative procedures, especially in the plastic surgery
field, NPWT plays an integral adjunct treatment to enhance dif-
ferent interventions in the reconstructive pathway. Commercial
negative pressure dressings are increasingly used in various
clinical settings and for many types of acute and chronic open
wounds.
Surgeons have recently discovered that foam-based negative
pressure dressings applied over closed incisions can also be
beneficial in preventing incision complications. The term
‘closed incision negative pressure therapy’ (ciNPT) refers to
any type of NPWT using foam-based dressings over closed
incisions.
Our goals were to investigate how ciNPT is beneficial in
preventing wound incision complications and then to formu-
late recommendations for potential indications for its use.
In December 2014, a multidisciplinary group of surgical
and infectious disease experts met to discuss the following
questions:
• Is there evidence-based data in the literature that reports
any benefits from using ciNPT?
• Which types of patients and closed surgical incisions are
at greatest risk for postoperative complications in the
different surgical specialty fields?
• Can evidence-based recommendations be formulated for
ciNPT use?
Materials and methods
Search of literature and selection of studies
A review of the literature was performed searching comput-
erised versions of MEDLINE (PubMed), EMBASE and the
Cochrane library. We further expanded the potential evidence
base using a ‘snowball’ system (i.e. continued searches in
the references of the self-researched publications). Search cri-
teria included (i) publications in all languages, (ii) various
Key Messages
• closed incision negative pressure therapy (ciNPT) use
may offer management of surgical incisions
• a literature search was conducted and a panel of experts
assembled to identify risk factors for surgical site com-
plications and create consensus recommendations for
ciNPT use over closed incisions
• patients with obesity, diabetes mellitus and a prolonged
surgical time are at high risk for developing surgical site
complications
• surgeons should assess the patient’s risk factors for sur-
gical site complications and the type of surgery per-
formed to identify individuals where ciNPT use could be
beneficial
• ciNPT is recommended for patients with one or more
comorbidity or in patients with a surgical incision that
is historically at high risk for developing surgical site
complications
study types [e.g. randomised clinical and experimental studies,
systematic and non-systematic reviews, meta-analyses, expert
opinions, case reports, experimental papers (animal and human
studies)] and (iii) consensus conference reports. The authors
received access to all publications in their full-published
versions.
Articles published in a peer-reviewed journal that was
considered relevant for the development and dissemination of
medical knowledge [i.e. an Abridged Index Medicus (AIM)
journal], supported the CONSORT statement, and a citation
impact factor of >0⋅5 were used.
Search period and search keywords
The search covered papers published in the period from Jan-
uary 2000 to February 2016. The keywords included ‘pre-
vention’, ‘NPWT’, ‘active incisional management’, ‘incisional
vacuum therapy’, ‘incisional NPWT’, ‘incisional wound vac-
uum assisted closure’, ‘closed incisional NPWT’, ‘wound
infection’ and ‘SSIs’.
An additional literature search was conducted to identify
risk factors for SSI development. Keywords included ‘SSI’,
‘wound infection’, ‘general surgery’, ‘open abdomen surgery’,
‘hernia repair’, ‘plastic surgery’, ‘reconstructive surgery’,
‘orthopaedic surgery’, ‘open reduction and internal fixation’,
‘vascular surgery’, ‘vascular bypass’, ‘cardiovascular surgery’,
‘sternotomy’ and ‘amputation’.
Criteria of evidence-based medicine
More than 50 different evidence level scales exist worldwide.
For the purpose of this study, we selected the 2009 Oxford
Centre for Evidence-based Medicine (EbM) classification
system (5).
Multidisciplinary consensus meeting
To formulate consensus guidelines, peer-reviewed published
literature focusing on ciNPT was used as the foundation for
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discussion and as evidence to support guideline statements.
Using a modified consensus process, described below, panel-
lists agreed on which patient risk factors and closed surgical
incisions were at the highest risk of SSIs and created an algo-
rithm for the use of ciNPT.
Selection of panellists
Leaders at Acelity (San Antonio, TX, USA), in conjunction
with the academic lead authors (CW, VSR), selected the 12
panellists based on their peer-reviewed publications on NPWT;
clinical experience with negative pressure for incision man-
agement; and reputation for scholarly activity in their respec-
tive fields. To create a heterogeneous expert panel, we selected
physicians who were from various geographic locations (US,
Italy, Germany and Denmark), had diverse practice experience
and represented several different surgical specialties (general,
orthopaedic, trauma, plastic, cardiac, podiatric and vascular
surgery) as well as clinical microbiology and infectious disease.
Developing the consensus recommendations
Before the meeting convened, all panellists reviewed the pub-
lications retrieved by the systematic literature review and
were briefed on the process for consensus building. The
one-and-a-half day meeting was divided into four sections: (i)
presentations (15–20 min) by each panellist reporting clinical
experience with ciNPT; (ii) collection of comments to all dis-
tributed literature and evaluation/rating of the available litera-
ture on ciNPT; (iii) review of definitions of closed incisions at
risk for complications and of patient-related risks; and (iv) open
discussion regarding appropriate use of ciNPT (i.e. algorithm).
By digitally recording all comments, the lead authors ensured
that all viewpoints were adequately captured and reviewed.
Participants did not reach conclusive recommendations at this
meeting; rather, they elected to reflect on definitions of closed
incisions at risk in various fields of surgery and to participate
in follow-up discussions via electronic mail and a follow-up
teleconference 12 weeks following the meeting. The panellists
received follow-up documents, including a general manuscript
outline and an assessment of ciNPT risk factors by surgical
specialty, for review (i.e. agree or disagree) and comment via
electronic mail. All participants reviewed comments made by
other participants with the goal of reaching unanimous agree-
ment, when possible, or consensus. The lead authors drafted a
manuscript that was reviewed and commented on by all pan-
ellists. All panellists agreed upon the final manuscript prior to
submission for publication.
Identifying risk factors and developing an algorithm
During the meeting, each panellist presented a list of risk factors
considered to be important when assessing patients for ciNPT
use. Each panellist also reviewed the resulting comprehensive
list of risk factors and provided relevant supporting EbM litera-
ture, when available. Panel members recommended ciNPT use
for risk factors with a reported odds ratio (OR) >2 or if the risk
factor was present in multiple surgical fields. Once the panel-
lists reached a consensus on risk factors, they created an algo-
rithm to identify at-risk scenarios in which ciNPT usage might
be beneficial for incision management. All panellists reviewed
and approved the algorithm.
Results
Type of ciNPT studies
A limited number of robust, prospective, randomised, com-
parative, controlled studies on ciNPT use over closed surgical
incisions that might most benefit from this therapy exist. The
literature search identified 100 publications that fulfilled the
above mentioned criteria. Of these, 60 articles describe out-
comes in a total of 2402 ciNPT-treated patients following surgi-
cal procedures, including orthopaedic (n= 21 articles, n= 852
patients), general (n= 22 articles, n= 869 patients), cardiotho-
racic (n= 8 articles, n= 505 patients), plastic (n= 6 articles,
n= 133 patients) or vascular (n= 6 articles, n= 95 patients).
Three articles have more than one surgical specialty and patient
population; thus, some patients and articles are counted twice.
The remaining 40 publications were literature reviews includ-
ing meta-analyses, editorials, research articles or experimen-
tal model descriptions. Three articles were solely devoted to
a health economic analysis (6–8), and three articles describe
study protocols of future studies (9–11). A majority of the 100
publications reported data based on one manufacturer’s sys-
tem: n= 91, KCI, an Acelity company, San Antonio, TX, USA;
n= 8, Smith and Nephew, plc, London, UK; n= 1, Daewoong
Pharmaceutical, Co, Ltd., Seoul, South Korea.
Of the 100 publications, 51 (51⋅0%) had authors based in the
US; 15 (15⋅0%) in Germany; 8 (8⋅0%) in Australia; 6 (6⋅0%)
in Italy; 4 (4⋅0%) in UK/Ireland; 3 (3⋅0%) each in Canada,
China and Spain; 2 (2⋅0%) in Turkey; and 1 (1⋅0%) each in
Denmark, Poland, South Korea, South Africa and the United
Arab Emirates.
Using the Oxford Centre for EbM evidence levels (Table 1)
(5), 51 (51⋅0%) included papers received a level 4 or 5 (reviews,
comparative historical studies, case series, case reports, eco-
nomic studies) and 39 (39⋅0%) received an evidence level of
3 or higher (comparative studies, meta-analyses). An addi-
tional 10 (10⋅0%) had no evidence level (research reports,
technical information, editorials, study protocol, experimental
study, etc.).
Main results of ciNPT studies
Preclinical studies evaluating ciNPT compared with standard
wound care reported reduced scar thickness and narrower scar
width, increased collagen at the incision site, increased mechan-
ical properties and increased tensile strength in the ciNPT
groups (12,13). In addition, using Laser Doppler flowmetry,
the peristernal perfusion after cardiac surgery was increased
among the patients who underwent negative pressure therapy
and decreased among the controls significantly (14). Mammary
artery harvesting reduced peristernal perfusion by 25⋅7% in the
controls, but negative pressure increased perfusion by 100%
after mammary harvesting (P= 0⋅04). Thus, ciNPT increased
perfusion relative to controls and compensated for reduced per-
fusion rendered by mammary artery harvesting, providing addi-
tional support in high-risk patients (14).
© 2016 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. 387
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Table 1 Evidence levels for the available literature on the subject of closed incision negative pressure therapy
EbM level Type of study Number of studies Percentage of studies (%)
No level Research reports, technical reports, editorial, guidelines 10 10⋅0
1a Systematic review of randomised controlled trials 6 6⋅0
1b Individual randomised controlled trials (with narrow confidence interval) 2 2⋅0
1c All-or nothing result* 0 0
2a Systematic review (with homogeneity) of cohort studies 2 2⋅0
2b Individual cohort study [including low-quality randomised controlled trials
(e.g. with a follow-up of<80%)]
11 11⋅0
2c ‘Outcomes’ research, ecological study 0 0
3a Systematic review (with homogeneity) of case–control studies 0 0
3b Individual case–control studies 18 18⋅0
4 Case series (and poor-quality cohort studies and case–control studies) 20 20⋅0
5 Expert opinion without explicit critical appraisal or based on physiology,
bench research or ‘first principles’
31 31⋅0
Total 100 100⋅0
EbM, evidence-based medicine
* If all patients died before the therapy was available but now some survive, or if some patients died but now all survive. Classification provided by
Centre for Evidence-Based Medicine (March 2009) (5).
Our review found a number of case studies, case series
and non-randomised controlled trials that described ciNPT
use. These studies included high-risk patients with one or
more comorbidities who underwent various surgical proce-
dures, including vascular bypass, sternotomy and caesarean
section (14–63). In 2013, Condé-Green et al. reported that
patients undergoing abdominal hernia repairs treated with
ciNPT had a lower surgical site occurrence (SSO) rates (22%
versus 63%, P= 0⋅02) and dehiscence (9% versus 38%,
P= 0⋅014) compared with patients treated with wound dress-
ings (17). In a retrospective study with a historical cohort
by Gibbs et al., (34) after controlling for body mass index
(BMI) and diabetes, wound complication rates in the ciNPT
group (n= 103) were found to be equivalent to those in the
standard dressing group (n= 867). Three other retrospective
studies with a historical control group observed lower rates of
SSI, SSOs, wound morbidity and re-operation in the ciNPT
group compared with the historical controls (16,51,63).Over-
all, a majority of these studies reported that ciNPT use was
associated with decreases in wound complications, wound
dehiscence, SSIs, haematoma/seroma formation and incisional
drainage.
Since 2004, numerous randomised controlled trials and indi-
vidual cohort studies have described ciNPT use (see Table 2).
These studies encompass various wound types and surgical
interventions, including traumatic injury repair, cardiothoracic
surgery, lower extremity amputations, arthroplasty, hernio-
plasty and vascular surgery (44,63–76). Enrolled patients often
had comorbidities, including obesity (BMI ≥30 kg/m2), dia-
betes mellitus, peripheral vascular disease or chronic obstruc-
tive pulmonary disease (15,67–69,77). Two studies reported
no differences in SSI rates or dehiscence between ciNPT and
control (silver-impregnated wound dressings or sterile gauze
dressings) groups (69,77). One study was stopped prematurely
because of blister formation in a majority of ciNPT group
patients (77). This adverse effect was most likely because of
improper dressing configuration and too high tension when
using the dressing as no other study reported adverse effects.
The majority of randomised controlled trials reported uni-
formly decreased SSI incidence, wound dehiscence and seroma
development in the ciNPT-treated group versus the control
groups (44,63–68,71,72,78). Stannard et al. examined out-
comes in 249 patients undergoing an orthopaedic procedure
for blunt trauma, resulting in 263 tibial plateau, pilon or cal-
caneus fractures (66). Fractures randomised to receive ciNPT
(n= 141), compared with standard of care (n= 122), had
lower SSI rates (P= 0⋅049) and wound dehiscence (P= 0⋅044).
Grauhan et al. reported a 4⋅5-fold decrease in wound infec-
tion rates in the ciNPT group (n= 75) compared with the
standard wound dressing group (n= 75; OR= 4⋅57; 95% con-
fidence interval= 1⋅23–16⋅94; P= 0⋅0266) in obese patients
(BMI≥ 30 kg/m2) following cardiac surgery (67).
Eight systematic reviews and meta-analyses were identi-
fied in the literature search (58,79–83). These studies have
examined the potential effects of ciNPT in reducing SSI,
seroma/haematoma formation and dehiscence as reported in
the literature. Each systematic review used different meth-
ods for data comparisons; however, four reviews indicated
that ciNPT use may help reduce rates of SSI (58,79,82,83).
ciNPT effects on seroma/haematoma formation and dehiscence
rate were inconclusive because of inconsistent data report-
ing. Two reviews stated that while evidence is mounting, no
definitive claims can be made as reported evidence is incon-
sistent (80,81). A recent meta-analysis evaluated the effec-
tiveness of ciNPT in lowering the incidence of surgical-site
infections compared with standard incisional care (84). This
study used a fixed-effects model to assess between-study and
between-incision location subgroup heterogeneity and effect
size. The authors demonstrated reduced overall weighted aver-
age rates of SSI in the ciNPT (6⋅61% versus 9⋅36%). The rel-
ative reduction of SSI rate was 29⋅4%, with the odds of SSI
rate decrease equalling 0⋅496 (P< 0⋅00001). Overall rates of
dehiscence were also reduced in ciNPT versus control groups
(5⋅32% and 10⋅68%, respectively). These results suggest that
ciNPT can be a potentially effective method for reducing SSI
and may be associated with decreased incidence of dehiscence.
388 © 2016 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.
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Figure 1 Closed incision negative pressure therapy risk factors assessment. Blue indicates low risk for SSI while red indicates high risk for SSI. ciNPT
use is recommended in patients with increased number of patient risk factors and incision risk factors. OB/GYN, obstetrics and gynaecology.
In total, despite the wide variety of surgical procedures and
patient comorbidities included in the 35 comparative studies
and analysed in eight systematic reviews, the majority reported
that patients treated with ciNPT showed reduced SSI rates with
the caveat that more large, randomised controlled trials are nec-
essary.
Risk factors in different surgical fields
Based on the EbM literature review and panel member
experience, the panel generated a list of risk factors for the
development of SSI shown in Table 3. Among comorbidities,
the most frequently cited are diabetes mellitus, American Soci-
ety of Anesthesiologists (ASA) physical classification system
score ≥3, advanced age, obesity (BMI≥ 30 kg/m2), tobacco
use, hypoalbuminaemia and corticosteroid use (85–99).
Most cited surgical incision risk factors for SSI development
included incisions after prolonged surgical time, re-operation
or re-exploration and emergency operation. In addition, inci-
sions in the presence of ischaemia (91), high perioperative
blood loss or high surgical tension also have an increased SSI
risk. Panel members also designated high tension, open groin
or sternotomy incisions as high-risk incisions where ciNPT use
is recommended.
Algorithm to use ciNPT
Based on the literature review and panel member experience,
we developed an algorithm for when a surgeon might consider
using ciNPT (Figure 1). In addition to the patient and surgical
incision risk factors listed above, ciNPT use may also be appro-
priate for incisions where infection can cause high morbidity,
such as sternotomy, open reduction and internal fixation with
hardware or groin area vascular surgery (especially if accom-
panied by a synthetic graft or vascular graft inserted below the
inguinal ligament). The group of authors decided against devel-
oping a score. Rather, the relevant risk factors for SSI are pre-
sented and must be considered in the light of each individual
patient’s situation.
Discussion
In open wounds, negative pressure therapy helps promote a
wound-healing environment by reducing oedema, removing
infectious materials and promoting perfusion and granulation
tissue formation (100–102). Recently, surgeons are using neg-
ative pressure therapy over closed incisions (ciNPT) in a variety
of clinical settings. ciNPT appears to manage the surgical inci-
sion by reducing incision line tension, decreasing oedema and
© 2016 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. 391
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providing an air tight seal. Using the results of the literature
search and panel member experiences, we summarised poten-
tial evidence-based benefits of ciNPT usage, identified both
patients and incisions that could potentially benefit from ciNPT
and created recommendations for the most appropriate use of
this treatment.
Every surgical procedure has its own set of risks for SSIs.
While many SSIs can be treated with antibiotics and/or superfi-
cial wound debridement, there are certain scenarios in which
wound infection has disastrous consequences, such as in a
lower extremity prosthetic bypass or joint replacement surgery.
As with specific procedures, patients with certain comor-
bidities are at increased risk of developing SSIs. The most
common patient and surgical operation risk factors identi-
fied by EbM and panel member experience were: obesity
(BMI ≥30 kg/m2), diabetes mellitus (e.g. 50% higher risk of
developing SSI following cardiac surgery), tobacco use, pro-
longed surgical time, ASA score ≥3 and corticosteroid use
(Table 3) (85,88,92,93,95,96,103–110). High-risk incisions
included those with specific characteristics (e.g. incisions that
were re-opened or under high tension) as well as those asso-
ciated with specific surgical procedures (e.g. pelvic surgery
incisions, sternotomy, extremity fractures, open reduction and
internal fixation and vascular groin surgery in which synthetic
grafts were used).
Using the above information, we created consensus rec-
ommendations for the most appropriate use of ciNPT (i.e. in
patients with one or more comorbidities or in patients with a
surgical incision that is historically at high risk for developing
SSIs) (Figure 1).
Despite the small number of ciNPT studies, in com-
parison to the large number on NPWT, current literature
supports its benefit in high-risk patients and incisions. A
majority of the 100 publications reported decreased rates
of SSIs, dehiscence and haematoma/seroma formation
(14–17,22–25,27–32,35–42,44,58,59,63–68,70,71,111–113).
A recent meta-analysis reported a 50% reduction in the rate
of SSIs in the ciNPT group compared with the control group
(OR 0⋅564; P< 0⋅00001) (84). Groin incisions were excluded
from the analysis. Nevertheless, this study further supports our
consensus recommendation. Adverse effects with ciNPT use
were only noted in one study (Howell et al.) (77), which was
stopped prematurely because of skin blister development at
the skin/dressing interface in 63% of the ciNPT group. This
adverse effect was most likely because of improper dressing
configuration (e.g. a lack of a non-adherent film dressing or
drape used to protect the skin from the foam dressing and too
high tension when using the dressing). It is noteworthy that
in this study, ciNPT was used for only 48 hours instead of
the recommended 7 days. No other study reported any skin
blistering or other adverse effects.
Treatment costs are an important issue in patient care. To
date, three studies examined the cost of ciNPT use (6–8)
and compared SSO rates and cost savings of ciNPT to rou-
tine incision care. Lewis et al. concluded that ciNPT may be
a cost-effective treatment for closed laparotomy incisions fol-
lowing removal of gynaecological cancers if it reduces SSO
rates (6). Tuffaha et al. examined use of ciNPT in obese
women following caesarean section. Here, ciNPT appeared
to be cost-effective compared with standard wound dressings,
although the authors note the high uncertainty surrounding the
decision to use ciNPT (7). Lastly, Echebiri and colleagues used
a computer model to evaluate the potential economic benefit for
prophylactic ciNPT after a caesarean section (8). The authors
provided evidence suggesting that ciNPT in high-risk patients
following caesarean section could be cost-beneficial (8). While
these results are encouraging, large cohort studies examining
cost savings in various surgical fields are needed.
Limitations exist in this study. The robustness of the consen-
sus recommendations is highly dependent upon the knowledge
experience, and objectivity of our panel members. These mem-
bers were carefully selected based on their personal familiar-
ity with the ciNPT system and their publications in the field.
Each reviewed the full literature available on the topic. Dur-
ing the in-person meeting, any potential panel members’ biases
were considered based on available evidence and vigorous
debates of our medical practices. An additional limitation was
the small number of prospective, randomised comparative stud-
ies identified in the literature search. Thus, the evidence-based
level of the available articles could skew the consensus guide-
lines because of a restricted evidence pool. Furthermore, we
acknowledge the potential bias introduced by the meeting spon-
sor (the manufacturer of the PREVENA™ Incision Manage-
ment System (KCI, an Acelity company, San Antonio, TX), one
ciNPT device).
To our knowledge, this is the first consensus document
attempting to better define the potential use of ciNPT to
reduce the incidence of SSIs. The panel believes that data
in the available literature, while limited, allows the surgeon
to determine a patient’s risk for a particular operative proce-
dure. In high-risk patients and high-risk surgical procedures,
ciNPT appears to have the potential to reduce surgical inci-
sion complications and surgical cost per patient up to $9000
(15,66,67), depending on the type of incision and patient risk
factors. With an estimated 8⋅7–58⋅2 million patients globally
developing an SSI, use of ciNPT may substantially reduce
these rates. As additional high-level, peer-reviewed publica-
tions become available, these consensus recommendations can
be updated.
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